Characterization, in vitro release, and pharmacokinetics of rupestonic acid derivative nanostructured lipid carriers optimized by Box-Behnken design
{{output}}
This study aimed to enhance the oral bioavailability of the rupestonic acid derivative CAM106 by developing nanostructured lipid carriers (NLCs) as its delivery system. CAM106-NLCs were prepared via the organic solvent evaporation method, with formulation opti... ...
